Single-cell transcriptional landscapes reveal HIV-1–driven aberrant host gene transcription as a potential therapeutic target

R Liu, YHJ Yeh, A Varabyou, JA Collora… - Science translational …, 2020 - science.org
R Liu, YHJ Yeh, A Varabyou, JA Collora, S Sherrill-Mix, CC Talbot Jr, S Mehta, K Albrecht…
Science translational medicine, 2020science.org
Understanding HIV-1–host interactions can identify the cellular environment supporting HIV-
1 reactivation and mechanisms of clonal expansion. We developed HIV-1 SortSeq to isolate
rare HIV-1–infected cells from virally suppressed, HIV-1–infected individuals upon early
latency reversal. Single-cell transcriptome analysis of HIV-1 SortSeq+ cells revealed
enrichment of nonsense-mediated RNA decay and viral transcription pathways. HIV-1
SortSeq+ cells up-regulated cellular factors that can support HIV-1 transcription (IMPDH1 …
Understanding HIV-1–host interactions can identify the cellular environment supporting HIV-1 reactivation and mechanisms of clonal expansion. We developed HIV-1 SortSeq to isolate rare HIV-1–infected cells from virally suppressed, HIV-1–infected individuals upon early latency reversal. Single-cell transcriptome analysis of HIV-1 SortSeq+ cells revealed enrichment of nonsense-mediated RNA decay and viral transcription pathways. HIV-1 SortSeq+ cells up-regulated cellular factors that can support HIV-1 transcription (IMPDH1 and JAK1) or promote cellular survival (IL2 and IKBKB). HIV-1–host RNA landscape analysis at the integration site revealed that HIV-1 drives high aberrant host gene transcription downstream, but not upstream, of the integration site through HIV-1–to–host aberrant splicing, in which HIV-1 RNA splices into the host RNA and aberrantly drives host RNA transcription. HIV-1–induced aberrant transcription was driven by the HIV-1 promoter as shown by CRISPR-dCas9–mediated HIV-1–specific activation and could be suppressed by CRISPR-dCas9–mediated inhibition of HIV-1 5′ long terminal repeat. Overall, we identified cellular factors supporting HIV-1 reactivation and HIV-1–driven aberrant host gene transcription as potential therapeutic targets to disrupt HIV-1 persistence.
AAAS